Why high-dose vitamin C kills cancer cells
Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.
Most vitamin C therapies involve taking the substance orally. However, the UI scientists have shown that giving vitamin C intravenously—and bypassing normal gut metabolism and excretion pathways—creates blood levels that are 100 – 500 times higher than levels seen with oral ingestion. It is this super-high concentration in the blood that is crucial to vitamin C’s ability to attack cancer cells.
Dr. Stegall’s comments: Vitamin C in IV form is an essential part of an integrative oncology treatment plan. We have multiple studies showing how it works inside the body, with a major advantage being that it harms cancer cells but not normal cells. As with most alternative therapies, more research is needed. However, I virtually always include it in my cancer treatment protocols and believe it is effective.
One caveat: IV vitamin C is not a very effective stand-alone treatment. I realize that there are a lot of articles touting the near-miraculous benefits of IV vitamin C, but I do not believe that it is effective by itself. A balanced approach, drawing from both conventional (allopathic) medicine and alternative (natural) medicine seems to be best.
Intravenous Vitamin C and Cancer
There is actually a wide spectrum of medical uses for vitamin C. Evidence exists documenting it as the best antiviral agent now available … IF used at the proper dose. Vitamin C can neutralize and eliminate a wide range of toxins. Vitamin C will enhance host resistance, greatly augmenting the immune system’s ability to neutralize bacterial and fungal infections. Now the National Institutes of Health has published evidence demonstrating vitamin C’s anti-cancer properties. With so many medical benefits, why do so few doctors know of them?
One explanation stems from ascorbic acid’s designation as a “vitamin.”
Dr. Stegall’s comments: The pioneering work of Dr. Linus Pauling taught us a lot about the wonders of vitamin C. Dr. Riordan built upon this knowledge, and used IV vitamin C as a cornerstone cancer treatment. It is one of the most-studied alternative cancer treatments, and research at the National Institutes of Health (NIH) is ongoing. Unfortunately, we do not have more long-term studies on IV vitamin C because such large trials require a significant amount of money. That money usually comes from pharmaceutical companies who hope to patent a drug. In the case of vitamin C, it cannot be patented so funding is an issue. Nonetheless, high quality smaller studies have occurred and they shed light on how intravenous vitamin C works inside the body against cancer cells. I am confident that it works well as part of an integrative approach.
Vitamin C kills tumor cells with hard-to-treat mutation
Maybe Linus Pauling was on to something after all. Decades ago the Nobel Prize–winning chemist was relegated to the fringes of medicine after championing the idea that vitamin C could combat a host of illnesses, including cancer. Now, a study published online today in Science reports that vitamin C can kill tumor cells that carry a common cancer-causing mutation and—in mice—can curb the growth of tumors with the mutation.
Like this article? Get all the latest cancer news and information
My research team scours the internet every day looking for the latest news on cancer diagnosis and treatment.
Subscribe below to receive a weekly email summary of the best articles on cancer news, nutrition, treatment, and the latest research developments.
If the findings hold up in people, researchers may have found a way to treat a large swath of tumors that has lacked effective drugs.
Dr. Stegall’s comments: With advances in testing, we are now able to detect specific mutations in cancer cells. Two such mutations – KRAS and BRAF – are particularly important because they tend to create cancer which is very aggressive as well as resistant to many treatments. IV vitamin C seems to target these mutations well, at least in mouse studies. Hopefully more studies on humans will take place. Nonetheless, we have plenty of evidence showing us how IV vitamin C works and that it is safe in humans, to the point that I believe we should use it in the treatment of most cancers.